For the year ended December 31, 2008, net income was $7.52 million, or $0.34 per diluted share, compared to $3.26 million, or $0.19 per diluted share, for the year ended December 31, 2007.
The company reported consolidated net sales of $96.9 million for the fourth quarter ended December 31, 2008, an increase of 52%, compared to $63.59 million for the fourth quarter of 2007. For the year ended December 31, 2008, consolidated net sales were $340.67 million, compared to $246.66 million for the year ended December 31, 2007.
Michael Moran, chairman, president and CEO of Allion Healthcare, said: “We are pleased to report solid fourth quarter and full year operating results across both of our business segments. The quarter was highlighted by the continued strong organic growth in the specialty HIV segment.
“Same store specialty HIV growth of 14% in the fourth quarter and 12% for the year, together with an expansion in our specialty HIV operating margins, validates both our strategic focus and operating effectiveness as we execute our low-cost business model over a broader patient population.”